www.ukhd.de/MolOnc
Ingrid Herr is an adjunct professor in molecular oncology and the leader of the Section Surgical Research of the University of Heidelberg. She has worked in translational oncology since 1995 and the obtained research data she has contributed to have made important contributions to the decryption of molecular signaling pathways of therapy resistance. Her current research topics include the influence of bioactive substances in the epigenetic regulation of tumor progression and therapy resistance with a focus on pancreatic cancer.
www.ukhd.de/MolOnc
Ingrid Herr is an adjunct professor in molecular oncology and the leader of the Section Surgical Research of the University of Heidelberg. She has worked in translational oncology since 1995 and the obtained research data she has contributed to have made important contributions to the decryption of molecular signaling pathways of therapy resistance. Her current research topics include the influence of bioactive substances in the epigenetic regulation of tumor progression and therapy resistance with a focus on pancreatic cancer.